SEC Form 4 · accession 0001078782-16-003581
VOLITIONRX LTD · VNRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Matthew Kratochvil
Officer — Chief Financial Officer
Period of report
Oct 5, 2016
Accepted (ET)
Oct 6, 2016 · 12:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000093314
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 5, 2016 | P | 10,000 | $5.00 | A | 10,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares were purchased by the reporting person in connection with an underwritten public offering by the Issuer. The offering closed on October 5, 2016. The reported sale price reflects the price at which the reporting person purchased the shares from the underwriters.